Clinical Trials Browser

Phase 1/2 × OTHER × Metastatic Pancreatic Ductal Adenocarcinoma × Clear all

NCT06904378 2026-05-19

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

NCT03450018 2024-05-24

SLC-0111-17-01

Phase 1/2 Terminated

Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma